Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars

PURPOSE: The aim of this study was to describe the implementation and uptake of biosimilar trastuzumab in Denmark compared with other European countries. METHODS: European data for usage of trastuzumab was supplied by IQVIA™, using the MIDAS® dataset. A comparison was performed based on market share...

Descripción completa

Detalles Bibliográficos
Autores principales: Azuz, Samuel, Newton, Max, Bartels, Dorthe, Poulsen, Birgitte Klindt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Pharmacoeconomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440249/
https://www.ncbi.nlm.nih.gov/pubmed/34008071
http://dx.doi.org/10.1007/s00228-021-03155-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440249/
https://www.ncbi.nlm.nih.gov/pubmed/34008071
http://dx.doi.org/10.1007/s00228-021-03155-4

Ejemplares similares